Cell-Free Methylated DNA Capture for Low-Abundance ctDNA Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for detecting circulating tumor DNA (ctDNA) are inadequate for sensitive and specific detection, especially in subjects with low abundance of ctDNA, necessitating improved techniques for cancer diagnosis and monitoring.
Innovation Solution
A method involving library preparation, methylated DNA capture, and sequencing of cell-free DNA, combined with methylation and mutation profiling, to identify cancer-specific DNA fragments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional ctDNA detection methods are used, then the detection process is simple, but the sensitivity and specificity are insufficient especially for low abundance ctDNA
Solution Approach 1:
The detection method is divided into multiple independent modules: (1) library preparation module with methylated DNA capture, (2) sequencing module, (3) data analysis module with machine learning classification. Each module can be optimized independently to improve overall detection precision while managing complexity through modular architecture.
Solution Approach 2:
Methylated DNA capture serves as an intermediary step between sample preparation and sequencing. This intermediate enrichment step specifically isolates methylated ctDNA fragments, significantly improving detection sensitivity and specificity by concentrating the target analyte before sequencing analysis.
2Measurement precision
If methylated DNA capture and sequencing are performed, then ctDNA detection sensitivity improves, but the time and resources required increase
Solution Approach 1:
Methylated DNA capture is performed as a preliminary enrichment step before sequencing. By pre-concentrating and purifying methylated ctDNA fragments in advance, the subsequent sequencing step requires less time and resources to achieve the same detection sensitivity, effectively reducing total process time.
Solution Approach 2:
The method optimizes multiple parameters including fragment length selection (100-200 bp), methylation enrichment efficiency, and sequencing depth. By carefully tuning these parameters, the protocol achieves high sensitivity while minimizing unnecessary time consumption in each processing step.
3Measurement precision
If fragment length filtering is applied to sub-population, then detection specificity improves, but the complexity of data analysis increases
Solution Approach 1:
The analysis focuses on specific local characteristics of ctDNA fragments, particularly fragment length distribution (100-200 bp range) and methylation patterns at specific genomic loci. By concentrating analysis on these localized features rather than entire genomes, specificity improves while computational complexity remains manageable.
Solution Approach 2:
The method transforms raw sequencing data into standardized parameters including fragment length bins, methylation beta-values, and classification scores. This parameter transformation simplifies complex high-dimensional data into interpretable metrics that maintain high diagnostic specificity while reducing analytical complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Achieves high sensitivity and specificity in detecting ctDNA, enabling cancer diagnosis and monitoring with improved accuracy and prognostic value.
Implementation Method 1
capturing cell-free methylated DNA using a binder selective for methylated polynucleotides
Data Source
AI summary
This is described herein, a method of capturing cell-free methylated DNA from a sample having less than 100 mg of cell-free DNA, comprising the steps of: subjecting the sample to library preparation to permit subsequent sequencing of the cell-free methylated DNA; adding a first amount of filler DNA to the sample, wherein at least a portion of the filler DNA is methylated; denaturing the sample; and capturing cell-free methylated DNA using a binder selective for methylated polynucleotides.